Q2 2017 Holdings
Filed 2017-08-14 | 22 holdings | $196.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $154.9M | 5,580,690 | 78.9% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $28.7M | 5,162,242 | 14.6% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $12.0M | 836,337 | 6.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $131.8K | 7,088,651 | 0.1% |
| Avexis Inc | COM | 05366U100 | $107.6K | 1,310,046 | 0.1% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $62.6K | 13,633,220 | 0.0% |
| Biohaven Pharmactl Hldg Co LTD(BHVN) | COM | G11196105 | $61.2K | 2,448,350 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $46.8K | 2,684,244 | 0.0% |
| Ignyta Inc | COM | 451731103 | $41.6K | 4,016,990 | 0.0% |
| Esperion Therapeutics Inc(ESPR) | COM | 29664W105 | $33.9K | 731,531 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $32.8K | 2,807,550 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $25.3K | 1,351,808 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $22.5K | 497,157 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $21.4K | 1,474,688 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $19.6K | 1,396,071 | 0.0% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $18.7K | 8,435,584 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $17.7K | 900,259 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $11.0K | 1,250,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $7.7K | 2,428,571 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $7.0K | 700,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.4K | 591,070 | 0.0% |
| Proteon Therapeutics Inc | COM | 74371L109 | $2.0K | 1,337,462 | 0.0% |